Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-7364
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance ; volume:12 ; number:1 ; day:20 ; month:11 ; year:2018 ; pages:1-13 ; date:12.2018
Human genomics ; 12, Heft 1 (20.11.2018), 1-13, 12.2018
- Creator
-
Langerud, Jonas
Jarhelle, Elisabeth
Van Ghelue, Marijke
Ariansen, Sarah Louise
Iversen, Nina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40246-018-0183-1
- URN
-
urn:nbn:de:101:1-2019010401535570526736
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Langerud, Jonas
- Jarhelle, Elisabeth
- Van Ghelue, Marijke
- Ariansen, Sarah Louise
- Iversen, Nina
- SpringerLink (Online service)
Other Objects (12)
Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
A new bioinformatics tool to help assess the significance of BRCA1 variants
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Fabry Disease with Genetic Variants of Unknown Significance and Concomitant Immunoglobulin A Nephropathy
Gene variants of unknown significance in Fabry disease: Clinical characteristics of c.376AG (p.Ser126Gly)
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
"Sequencing-grade" screening for BRCA1 variants by oligo-arrays
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history
Splice variants of RAS—translational significance
Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
A new bioinformatics tool to help assess the significance of BRCA1 variants
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Fabry Disease with Genetic Variants of Unknown Significance and Concomitant Immunoglobulin A Nephropathy
Gene variants of unknown significance in Fabry disease: Clinical characteristics of c.376AG (p.Ser126Gly)
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
"Sequencing-grade" screening for BRCA1 variants by oligo-arrays
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history
Splice variants of RAS—translational significance
Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
A new bioinformatics tool to help assess the significance of BRCA1 variants
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Fabry Disease with Genetic Variants of Unknown Significance and Concomitant Immunoglobulin A Nephropathy
Gene variants of unknown significance in Fabry disease: Clinical characteristics of c.376AG (p.Ser126Gly)
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
"Sequencing-grade" screening for BRCA1 variants by oligo-arrays
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history